60 results
8-K
EX-99.1
ngkkf eccfqngv6xx
30 Jun 23
Zai Lab and argenx Announce Approval of VYVGART® (efgartigimod alfa injection) for Generalized Myasthenia Gravis in China
4:18pm
8-K
EX-99.1
vm8 5mu9vus
9 May 23
Zai Lab Announces First Quarter 2023
4:03pm
8-K
EX-99.1
va9wt5243y
9 Aug 22
Zai Lab Announces Second Quarter 2022
12:00am
8-K
EX-99.1
eusg56 4ac9r
1 Mar 22
Results of Operations and Financial Condition
4:17pm
8-K
56csqh8nh8u mbfb
3 Dec 21
Zai Lab Announces Inclusion of ZEJULA® (Niraparib) in China’s National Reimbursement Drug List for First-Line Ovarian Cancer
7:45am